©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid, but Not N-Methyl-

D

-aspartate, Activates Mitogen-activated Protein Kinase through G-protein Subunits in Rat Cortical Neurons (*)

(Received for publication, July 21, 1995)

Yizheng Wang Jon P. Durkin (§)

From the Cellular Neurobiology Group, Institute for Biological Sciences, National Research Council of Canada, Ottawa, Ontario K1A 0R6, Canada

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES

ABSTRACT

alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor channels play important roles in plasticity, neurotransmission, and neurotoxicity in the central nervous system. AMPA, but not N-methyl-D-aspartate (NMDA), receptor signaling in rat cortical neurons was found to involve a G-protein coupled to a protein kinase cascade. While both NMDA and AMPA activated p mitogen-activated protein kinase (MAPK) in neurons, only AMPA-induced MAPK was inhibited by pertussis toxin. AMPA, but not NMDA, caused an association of a G-protein beta subunit with a Ras, Raf kinase, and MAP/ERK kinase (MEK)-1 complex. The evidence indicates that AMPA triggers MAPK activation via a novel mechanism in which G-protein beta dimers released from Galpha bind to a Ras protein complex causing the activation of Ras, Raf kinase, MEK-1, and finally MAPK.


INTRODUCTION

Glutamate is the major excitatory amino acid in the brains of vertebrates, and its receptors are believed to mediate a wide range of physiological and pathological processes including neurotransmission, plasticity, excitotoxicity, and various forms of neurodegeneration(1) . Many of the actions of glutamate are coupled to the influx of extracellular Ca mediated directly or indirectly by NMDA (^1)receptors present on neurons(1, 2) . More recently, it has been determined that the AMPA glutamate receptor, which normally passes Na, is also directly Ca-permeable (3, 4) and can be an important source of Ca influx in some types of neurons(3, 4, 5) . Transient changes in intracellular Ca are known to trigger a plethora of cellular responses in neurons including the activation of protein kinases and phosphatases and changes in gene expression(1, 2) . The NMDA-mediated entry of Ca has been shown to activate MAPK(6) , a serine/threonine kinase known to be important in the transmission of extracellular signals to the nucleus of cells(7, 8, 9) . While the exact role and impact of NMDA-activated MAPK in neuronal cells is unclear, it may be that MAPK serves as a conduit through which NMDA receptor-mediated Ca signals are converted into relevant nuclear responses. By contrast, it is not known if the entry of Ca via AMPA glutamate receptors is coupled to signaling pathways responsible for the activation of MAPK in neurons.

It is becoming increasingly evident that the influx of Ca through different ion channels can elicit distinct cellular responses in neurons(2) . For example, the entry of Ca through NMDA receptors and L-type voltage-sensitive calcium channels (VSCCs) have been shown to transmit signals to the nucleus and to regulate gene expression through two distinct signaling pathways (10) . It is therefore possible that mechanisms may be present in neurons by which different Ca ion channels can differentially activate MAPK through distinct signaling pathways. In the present study we investigated whether Ca entry through the AMPA glutamate receptor stimulates MAPK in rat cortical neurons, and if so, whether the mechanism of MAPK activation by AMPA is different from that induced by NMDA.


EXPERIMENTAL PROCEDURES

Materials

AMPA and NMDA were purchased from RBI; anti-Ras monoclonal antibody Y13-259 from Oncogene Science; anti-G-protein beta subunit from DuPont NEN; and anti-B-Raf kinase and anti-MEK-1 antibodies from Santa Cruz. All other reagents were from Sigma.

Primary Neuron Cultures

Cerebral cortical cultures, prepared from 18-day-old fetal rats(11) , were plated on poly(L-lysine)-coated 12-well plates (for kinase assays) at 5 times 10^6 cells/ml in DMEM supplemented with 2 µML-glutamine, 30 mM glucose, 10% heat-inactivated fetal bovine serum, and 10% horse serum. After 3 days, 15 mg/ml 5-fluoro-2`-deoxyuridine and 35 mg/ml uridine were added to inhibit non-neuronal cell growth(12) . Greater than 90% of the cells were neurons based on morphology and negative GFAB staining. Cultures were used for experiment 10-13 days after plating. Unless stated, cultures were rinsed twice and placed in DMEM without serum immediately before experiments were initiated. For Na-free conditions, the cells were incubated in a solution containing 120 mM choline chloride, 5.4 mM KCl, 0.8 mM CaCl(2), 15 mM glucose, and 25 mM Tris-HCl, pH 7.4.

MAPK Assay

MAPK activity was measured as described previously(13) . Briefly, cultures were rinsed 3 times with cold PBS containing 10 mM NaF and 1 mM PMSF, and the cells were extracted by incubation in Triton X-100 lysis buffer (13) for 30 min at 4 °C. Extracts (60 µg of protein) were incubated with protein A-Sepharose beads preabsorbed with preimmune serum for 1 h, clarified by centrifugation at 10,000 times g for 15 min, and then incubated for 2 h with an anti-p MAPK antibody (14) absorbed to protein A-Sepharose. The immunocomplex formed was collected by centrifugation, washed 4 times with lysis buffer (0.5% Triton X-100), and resuspended in kinase buffer (20 mM Hepes, pH 7.4, 10 mM MgCl(2), 1 mM dithiothreitol, and 10 mM beta-nitrophenyl phosphate). MAPK activity in the immunoprecipitate was measured as the extent of incorporation of P into MBP(13) . Phosphorylated MBP, separated by SDS-PAGE, was visualized by autoradiography or quantitated by the scintillation counting of excised bands.

GTP Loading Assay

Cortical neurons plated in 6-well plates at 5 times 10^6/ml treated with or without 100 ng/ml PTX for 20 h were metabolically labeled with 0.5 mCi/ml [P]H(3)PO(4) in PO(4)-free DMEM for 4 h and then treated with 100 µM AMPA for 2 min. The immunoprecipitation of Ras was as described(15) . Briefly, cells were washed twice with cold PBS containing 10 mM NaF and 1 mM PMSF and lysed in 0.5 ml of buffer (20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM MgCl(2), 1% Triton X-100) containing 1 µg of the anti-Ras monoclonal antibody Y13-259. After clearing the extracts with a charcoal slurry, protein A-Sepharose coupled with goat anti-rat IgG was added, and the extracts were incubated for 2 h at 4 °C. Samples were collected by centrifugation, washed, resuspended in 1 M KH(2)PO(4), and incubated at 85 °C for 3 min. Samples were separated by polyethyleneimine cellulose thin layer chromatography and visualized by autoradiography. The percent GTP was calculated as density of GTP/(density of GTP + density of GDP).

Detection of the RasbulletG-protein betabulletRafbulletMEK-1 Complex

Neurons grown on 10-cm dishes (5 times 10^6/ml) were treated with 100 µM AMPA, 100 µM NMDA, or 50 mM KCl for 3 min. Cultures were rinsed twice with cold PBS containing 10 mM NaF and 1 mM PMSF and 1 ml of extraction buffer (20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM MgCl(2), 0.5% Triton X-100, 1 mM NaF, 20 mM sodium orthovanadate, 1 µg/ml leupeptin, 1 mM PMSF, 1 µM pepstatin A, and 1.0% bovine serum albumin) containing 20 µg of anti-Ras antibody Y13-259 was added. Cells were scraped and lysed by 20 passages through a 21-gauge needle. A 1:10 v/v charcoal slurry was added and the extracts incubated for 1 h at 4 °C. Clarified supernatants, obtained by centrifugation, were incubated with protein A-Sepharose preabsorbed with goat anti-rat IgG overnight at 4 °C. The beads were collected, washed three times in buffer (20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 20 mM EGTA, and 0.5% Triton X-100) and once in PBS, and the immunoprecipitate was subjected to SDS-10% PAGE followed by electrotransfer to Immobilon-P (Millipore). The Immobilon-P was blocked for 1.5 h with 0.5% bovine serum albumin and 5% powder milk in PBS, washed twice with PBS, and incubated overnight at 4 °C with the antibodies specified in the legends to Fig. 3and Fig. 4. The Immobilon-P was then washed 3 times with PBS containing 0.1% SDS, incubated with a horseradish peroxidase-conjugated goat anti-rabbit secondary antibody for 1.5 h, and washed 5 times with PBS containing 0.1% SDS. The bands were visualized by an Amersham ECL system.


Figure 3: AMPA, but not NMDA or KCl, causes the association of a G-protein beta subunit with Ras complex. Following the treatments indicated below, Ras immunoprecipitates were subjected to SDS-10% PAGE, electrotransferred, and probed with an anti-G-protein beta subunit antibody as described (16) . The blots were then stripped and reprobed with an anti-Ras antibody(16) . A, untreated controls or cultures treated with 100 ng/ml PTX for 20 h were stimulated with 100 µM AMPA for 3 min. B, cultures were left unstimulated (laneC) or were stimulated with 100 µM AMPA (laneA), 100 µM NMDA (laneN), or 50 mM KCl (laneK) for 3 min. C, the effect of extracellular Ca on the coprecipitation of G-protein beta subunit with Ras. Cultures were incubated in DMEM with or without 2.4 mM Ca for 15 min and then stimulated with the indicated doses of AMPA for 3 min.




Figure 4: The association of Raf kinase and MEK-1 with Ras in neurons stimulated by AMPA. Cultures were treated with AMPA as described in the legend to Fig. 3, and the immunocomplex precipitated by the Ras antibody was separated, transferred, and blotted with the following antibodies (16) : A and B, anti-B-Raf or C, anti-MEK-1.




RESULTS AND DISCUSSION

AMPA, NMDA, and KCl-induced depolarization all caused transient 2.5-fold increases in MAPK activity in primary rat cortical neurons, which peaked 3 min after treatment (Fig. 1A). However, whereas MAPK activity returned to near basal levels within 10 min of NMDA or KCl addition, AMPA-stimulated MAPK declined gradually over a 20-60-min period (Fig. 1A). The mechanism responsible for the prolonged activation of MAPK by AMPA was further investigated.


Figure 1: Effects of AMPA, NMDA, and KCl on MAPK activation. A, cortical neurons (24) were stimulated with AMPA, NMDA, or KCl and at the indicated times MAPK activity was determined (25) by the ability of immunocomplexed MAPK to phosphorylate myelin basic protein (MBP). B, MAPK activity was determined in neuronal cultures treated with the indicated concentrations of AMPA for 3 min. C and D, neurons incubated in medium with or without Ca or Na(24) , respectively, were treated with the indicated agents for 3 min before MAPK activity was determined. E, neurons were treated with 5 µM nifedipine for 15 min and then challenged with the indicated agents for 3 min before MAPK activity was determined. For A, C, D, and E the concentrations of AMPA, NMDA, KCl, and epidermal growth factor (EGF) were 100 µM, 100 µM, 50 mM, and 100 ng/ml, respectively. Each point is the mean ± S.E. of radioactivity incorporated into myelin basic protein of three separate experiments in triplicate.



AMPA induced a dose-dependent increase of MAPK activity (Fig. 1B). The stimulation of MAPK by AMPA, NMDA, and KCl, but not epidermal growth factor, was abolished when cortical neurons were incubated in Ca-free medium (Fig. 1C). However, the increase in MAPK activity by AMPA was unperturbed by incubation in Na-free medium (Fig. 1D), indicating that the influx of Na and/or Na-induced depolarization through the AMPA receptor was not responsible for MAPK activation. Moreover, while the L-type VSCC blocker, nifedipine(15) , abolished the stimulation of MAPK activity mediated by KCl-induced depolarization, it had no effect on the activation of MAPK by either AMPA or NMDA (Fig. 1E). This finding is in agreement with a previous report (6) demonstrating that glutamate and NMDA-stimulated MAPK activity is a Ca-dependent, VSCC-independent process. Thus, L-type VSCCs appear linked to the depolarization-induced activation of MAPK by KCl, whereas the entry of Ca via these channels was not likely a significant factor in MAPK activation by AMPA. The increase in MAPK activity by AMPA was blocked by pretreatment of neurons with the selective AMPA receptor antagonist, CNQX, but not by the NMDA channel blocker, MK801, or MCPG, a metabotropic receptor blocker. Furthermore, trans-(1S,3R)-ACPD, a glutamate metabotropic receptor agonist, did not stimulate MAPK activity (data not shown). Collectively, these results indicate that the influx of Ca directly through the AMPA receptor itself was likely responsible for the protracted activation of MAPK by AMPA in rat cortical neurons.

MAP kinase activation arises from a protein kinase cascade, which in some cells involves protein kinase C (PKC)(16, 17) . However, the down-regulation of PKC (18) in neurons by chronic exposure to the phorbol ester, phorbol 12-myristate 13-acetate (PMA), did not alter AMPA-induced activation of MAPK, although it did ablate MAPK stimulation triggered by acute exposure to phorbol 12-myristate 13-acetate (Fig. 2A). Moreover, the potent PKC inhibitor, calphostin C, had no effect on AMPA-induced MAPK (data not shown). Therefore, the activation of MAPK by AMPA was clearly a PKC-independent process.


Figure 2: AMPA activates Ras and MAPK through a PTX-dependent but PKC-independent pathway. A, neurons were treated with 100 nM PMA (TPA) for 20 h and stimulated with 100 µM AMPA or 100 nM PMA for 3 min. MAPK activity was then determined(25) . Results represent the mean ± S.E. of three separate determinations in triplicate. B, untreated controls or cultures treated with 100 ng/ml PTX for 20 h were labeled with [P]H(3)PO(4) for 4 h and then stimulated with 100 µM AMPA for 2 min. Ras was immunoprecipitated from cell lysates, and bound guanine nucleotides were separated by thin layer chromatography(11) . C, densitometric determinations of GTP/(GTP + GDP) ratios from the autoradiograph presented in B. The results are representative of six separate determinations. D, untreated controls or cultures treated with 100 ng/ml PTX for 20 h were left unstimulated or were stimulated with 100 µM AMPA, 100 µM NMDA, or 50 mM KCl for 3 min before MAPK activity was determined. Results are representative of the mean ± S.E. of three experiments in triplicate. MBP, myelin basic protein.



It is well established that the Ras protein occupies a pivotal position in the cascade activation of MAPK(19, 20, 21, 22, 23, 24) . Exposing cortical neurons to AMPA rapidly caused about a 30% increase of Ras activity (Fig. 2, B and C) measured as the ratio of the GTP- to GDP-bound form of the protein. Since Ras-dependent activation of MAPK has been associated with receptors coupled to G-proteins (25, 26, 27) and receptors with intrinsic tyrosine kinase(28) , we studied the effects of PTX on AMPA-induced MAPK activation. Surprisingly, pretreating cortical neurons with PTX inhibited the increase in MAPK seen with AMPA but not that observed with either NMDA or KCl (Fig. 2D). Moreover, the increase in Ras activity effected by AMPA was sensitive to PTX treatment (Fig. 2, B and C), indicating that the activation of MAPK through the AMPA receptor, but not the NMDA receptor, involved a PTX-sensitive G-protein (presumably a member of the G(i) family of proteins) apparently coupled to the AMPA-induced stimulation of Ras in cortical neurons.

Although most G-protein-mediated processes are modulated by activated alpha subunits, it is now evident that the beta subunits of G-proteins can also regulate the activity of various effectors(29, 30, 31, 32, 33) . As shown in Fig. 3A, a G-protein beta subunit was found in the immunocomplex precipitated by an anti-Ras antibody in AMPA-challenged neurons but not in control cultures. By contrast, neither NMDA nor KCl stimulation resulted in the coprecipitation of a beta subunit with Ras (Fig. 3, B and C). The AMPA-induced association of the beta subunit with the Ras immunocomplex was dose-dependent (Fig. 3D) and substantially reduced in cultures subjected to PTX pretreatment (Fig. 3A). As was the case with AMPA-stimulated MAPK, the coprecipitation of the beta subunit with Ras was dependent on extracellular Ca (Fig. 3C) but not Na (data not shown). These findings strongly suggest that AMPA, but not NMDA or KCl, induced a dissociation of G from beta dimers and that the subsequent binding of the free beta subunit to Ras protein, probably through its pleckstrin homology domain(34, 35, 36) , stimulated a downstream cascade leading to MAPK activation.

If a G-protein dependent activation of Ras is an early step in the AMPA-induced stimulation of MAPK, then the downstream involvement of Raf kinase could be anticipated(37, 38, 39, 40) . Since B-raf transcripts are found at their highest levels in brain (41) and B-Raf, rather than Raf-1, is responsible for nerve growth factor-stimulated MEK-1 activation in PC12 cells(42) , we determined whether stimulating cortical neurons with AMPA caused the coprecipitation of B-Raf with Ras. As shown in Fig. 4A, while both the p and p forms of Raf kinase were detected in the immunocomplex precipitated by the anti-Ras antibody, only the levels of p kinase were increased after exposing neurons to AMPA. Moreover, the p kinase that coprecipitated with Ras in AMPA-challenged neurons exhibited a slow gel mobility shift, an indicator of Raf kinase activation(38) . As was observed with the beta subunit, the coprecipitation of p with Ras was dependent on extracellular Ca (Fig. 4B). We next determined whether MEK-1 (MAP kinase/ERK-activating kinase) was present in the complex containing G-protein beta subunit and Raf kinase. MEK acts immediately downstream of Raf kinase, and upon its phosphorylation and activation, it phosphorylates and activates MAPK(43, 44) . As demonstrated in Fig. 4C, while there was no indication of an increased association of MEK-1 with the Ras complex precipitated from AMPA-stimulated cells, an AMPA dose-dependent activation of MEK-1 was observed, measured as a slow gel mobility shift of the protein. Both the binding of MEK-1 to the Ras complex and its subsequent activation by AMPA were found to be dependent on extracellular Ca (data not shown).

The results of this study are consistent with the hypothesis that the transmembrane influx of Ca through AMPA receptors induces the dissociation of G from a PTX-sensitive G-protein, and that once released, the G subunit is responsible for initiating a cascade of events involving the activation of Ras, p kinase, MEK-1, and finally MAPK. This novel mechanism of MAPK activation in cortical neurons appears distinct from that responsible for increased MAPK activity effected by NMDA and KCl. The evidence also indicates that while AMPA, like NMDA and KCl-mediated depolarization, activates MAPK by processes dependent on the influx of extracellular Ca, it is apparent that different routes of Ca entry trigger different mechanisms leading to MAPK activation. This conclusion is in agreement with a recent report indicating that NMDA and L-type Ca channels activate calmodulin II kinase in neurons by two distinct signaling pathways that are coupled to different routes of Ca entry(2) . It is reasonable to suggest that neurons could use these different paths to MAPK activation to generate divergence in the downstream signals and cellular responses to MAPK activity. Elucidating the signaling pathways specifically coupled to the entry of Ca through AMPA, NMDA, VSCCs, and other ionotropic channels will facilitate our understanding of the role these receptors play in neurons under both physiological and pathological conditions.


FOOTNOTES

*
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§
To whom correspondence should be addressed. Tel.: 613-993-4754; Fax: 613-941-4475.

(^1)
The abbreviations used are: NMDA, N-methyl-D-aspartate; AMPA, alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; MAPK, mitogen-activated protein kinase; VSCC, voltage-sensitive calcium channel; MEK, MAP/ERK kinase; DMEM, Dulbecco's modified Eagle's medium; PBS, phosphate-buffered saline; PMSF, phenylmethylsulfonyl fluoride; PAGE, polyacrylamide gel electrophoresis; PTX, pertussis toxin; PKC, protein kinase C; PMA, phorbol 12-myristate 13-acetate.


ACKNOWLEDGEMENTS

We thank R. Tremblay and D. Song for excellent technical assistance and R. Walker for critical comments.


REFERENCES

  1. Choi, D. W. (1988) Neuron 1,623-634 [Medline] [Order article via Infotrieve]
  2. Ghosh, A., and Greenberg, M. E. (1995) Science 268,239-247 [Medline] [Order article via Infotrieve]
  3. Schneggenburger, R., Zhou, Z., Konnerth, A., and Neber, E. (1993) Neuron 11,133-143 [Medline] [Order article via Infotrieve]
  4. Brorson, J. R., Manzolillo, P. A., and Miller, R. J. (1994) J. Neurosci. 14,187-197 [Abstract]
  5. Hollmann, M., and Heinemann, S. (1994) Annu. Rev. Neurosci. 17,31-108 [CrossRef][Medline] [Order article via Infotrieve]
  6. Bading, H., and Greenberg, M. E. (1991) Science 253,912-914 [Medline] [Order article via Infotrieve]
  7. Chen, R-H., Sarnecki, C., and Blenis, J. (1992) Mol. Cell. Biol. 12,915-927 [Abstract]
  8. Blenis, J. (1993) Proc. Natl. Acad. Sci. U. S. A. 90,5889-5892 [Abstract]
  9. Ahn, N. G., Seger, R., and Krebs, E. G. (1992) Curr. Opin. Cell Biol. 4,992-999 [Medline] [Order article via Infotrieve]
  10. Rosen, L., Ginty, D. D., and Greenberg, M. E. (1993) Science 260,181-186 [Medline] [Order article via Infotrieve]
  11. Dicther, M. A. (1973) Brain Res. 149,279-293
  12. Blac, M. A. J. (1995) Neurochem. Res. , in press
  13. Meloche, S., Pages, G., and Pouyssegur, J. (1992) J. Mol. Biol. 3,63-71
  14. Wang, Y. Z., Simonson, M. S., Pouyssegur, J., and Dunn, M. J. (1992) Biochem. J. 287,589-594 [Medline] [Order article via Infotrieve]
  15. Rosen, L., Ginty, D. D., Weber, M. J., and Greenberg, M. E. (1994) Neuron 12,1207-1221 [Medline] [Order article via Infotrieve]
  16. L'Allemain, G., Sturgill, T. M., and Weber, M. J. (1991) Mol. Cell. Biol. 11,1002-1008 [Medline] [Order article via Infotrieve]
  17. Johnson, G. L., and Vaillancourt, R. R. (1994) Curr. Opin. Cell Biol. 6,230-238 [Medline] [Order article via Infotrieve]
  18. Chida, N., Kato, N., and Kuroki, T. (1986) J. Biol. Chem. 261,13013-13018 [Abstract/Free Full Text]
  19. Thomas, S. M., DeMarco, M., D'Arcangelo, G., Halegoua, S., and Brugge, J. S. (1992) Cell 68,1031-1040 [Medline] [Order article via Infotrieve]
  20. Wood, K. W., Sarnecki, C., Roberts, T. M., and Blenis, J. (1992) Cell 68,1041-1050 [Medline] [Order article via Infotrieve]
  21. Vojtek, A. B., Hollenberg, S. M., and Cooper, J. A. (1993) Cell 74,205-214 [Medline] [Order article via Infotrieve]
  22. Moodie, S. A., Willumsen, B. M., Weber, M. J., and Wolfman, A. (1993) Science 260,1658-1661 [Medline] [Order article via Infotrieve]
  23. Minden, A., Lin, A., McMahon, M., Lange-Carte, C., Derijard, B., Davis, R. J., Johnson, G. J., and Karin, M. (1994) Science 266,1719-1723 [Medline] [Order article via Infotrieve]
  24. Davis, R. J. (1994) Trends Biochem. Sci. 19,470-473 [CrossRef][Medline] [Order article via Infotrieve]
  25. Gardner, A. M., Vaillancourt, R. R., and Johnson, G. L. (1993) J. Biol. Chem. 268,17896-17901 [Abstract/Free Full Text]
  26. Winitz, S., Russell, M., Qian, N-X., Gardner, A., Dwyer, L., and Johnson, G. L. (1993) J. Biol. Chem. 268,19196-19199 [Abstract/Free Full Text]
  27. Alblas, J., van Corven, E. J., Hordijk, P. L., Milligan, G., and Moolenaar, W. H. (1993) J. Biol. Chem. 268,22235-22238 [Abstract/Free Full Text]
  28. Blumer, K. J., and Johnson, G. L. (1994) Trends Biochem. Sci. 19,236-240 [CrossRef][Medline] [Order article via Infotrieve]
  29. Tang, W-J., and Gilman, A. G. (1991) Science 254,1500-1503 [Medline] [Order article via Infotrieve]
  30. Federman, A. D., Conklin, B. R., Schrader, K. A., Reed, R. R., and Bourne, H. R. (1992) Nature 356,159-161 [CrossRef][Medline] [Order article via Infotrieve]
  31. Neer, E. J. (1995) Cell 80,249-257 [Medline] [Order article via Infotrieve]
  32. Crespo, P., Xu, N., Simonds, W. F., and Gutkin, J. S. (1994) Nature 369,418-420 [CrossRef][Medline] [Order article via Infotrieve]
  33. Koch, W. J., Hawes, B. E., Allen, L. F., and Lefkowitz, R. J. (1994) Proc. Natl. Acad. Sci. U. S. A. 91,12706-12710 [Abstract/Free Full Text]
  34. Lefkowitz, R. J. (1993) Cell 74,409-412 [Medline] [Order article via Infotrieve]
  35. Pawson, T. (1995) Nature 373,573-580 [CrossRef][Medline] [Order article via Infotrieve]
  36. Inglese, J., Koch, W. J., Touhara, K., and Lefkowitz, R. J. (1995) Trends Biochem. Sci. 20,151-155 [CrossRef][Medline] [Order article via Infotrieve]
  37. Kyriakis, J. M., App, H., Zhang, X-F., Banerjie, P., Brautigan, D. L., Rapp, U. P., and Avruch, J. (1992) Nature 358,417-421 [CrossRef][Medline] [Order article via Infotrieve]
  38. Daum, G., Eisenmann-Tappe, I., Fries, H-W., Troppmair, J., and Rapp, U. R. (1994) Trends Biochem. Sci. 19,474-480 [CrossRef][Medline] [Order article via Infotrieve]
  39. Leevers, S. L., Paterson, H. F., and Marshall, C. J. (1994) Nature 369,411-414 [CrossRef][Medline] [Order article via Infotrieve]
  40. Stokoe, D., Macdonald, S. G., Gadwallader, K., Symons, M., and Hancock, J. F. (1994) Science 264,1463-1467 [Medline] [Order article via Infotrieve]
  41. Storm, S. M., Cleveland, L., and Rapp, R. U. (1990) Oncogene 5,345-351 [Medline] [Order article via Infotrieve]
  42. Jaiswal, R. K., Moodie, A., Wolfman, A., and Landreth, G. L. (1994) Mol. Cell. Biol. 14,6944-6953 [Abstract]
  43. Crews, C., Alessandrini, A. A., and Erikson, R. L. (1992) Science 258,478-480 [Medline] [Order article via Infotrieve]
  44. Crews, C., Alessandrini, A. A., and Erikson, R. J. (1992) Cell Growth & Differ. 3,135-142

©1995 by The American Society for Biochemistry and Molecular Biology, Inc.